DK1073462T3 - Kombinationsvaccine mod hepatitis A og hepatitis B - Google Patents

Kombinationsvaccine mod hepatitis A og hepatitis B

Info

Publication number
DK1073462T3
DK1073462T3 DK99924871T DK99924871T DK1073462T3 DK 1073462 T3 DK1073462 T3 DK 1073462T3 DK 99924871 T DK99924871 T DK 99924871T DK 99924871 T DK99924871 T DK 99924871T DK 1073462 T3 DK1073462 T3 DK 1073462T3
Authority
DK
Denmark
Prior art keywords
hepatitis
vaccine against
combination vaccine
against hepatitis
combination
Prior art date
Application number
DK99924871T
Other languages
English (en)
Inventor
Claude Artois
Michael J Clark
Clothilde Thiriart
Stefan Gabriel Jozef Thoelen
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of DK1073462T3 publication Critical patent/DK1073462T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DK99924871T 1998-05-01 1999-04-27 Kombinationsvaccine mod hepatitis A og hepatitis B DK1073462T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9809507.8A GB9809507D0 (en) 1998-05-01 1998-05-01 Novel composition
PCT/EP1999/003024 WO1999056772A2 (en) 1998-05-01 1999-04-27 Hepatitis vaccine

Publications (1)

Publication Number Publication Date
DK1073462T3 true DK1073462T3 (da) 2007-02-26

Family

ID=10831426

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99924871T DK1073462T3 (da) 1998-05-01 1999-04-27 Kombinationsvaccine mod hepatitis A og hepatitis B

Country Status (29)

Country Link
EP (1) EP1073462B1 (da)
JP (2) JP5138843B2 (da)
KR (1) KR100612547B1 (da)
CN (1) CN1263509C (da)
AR (1) AR016987A1 (da)
AT (1) ATE345815T1 (da)
AU (1) AU743759B2 (da)
BR (1) BR9910157A (da)
CA (1) CA2331086C (da)
CO (1) CO5050367A1 (da)
CY (1) CY1107322T1 (da)
CZ (1) CZ301232B6 (da)
DE (1) DE69934108T2 (da)
DK (1) DK1073462T3 (da)
ES (1) ES2277437T3 (da)
GB (1) GB9809507D0 (da)
GC (1) GC0000101A (da)
HK (1) HK1034202A1 (da)
HU (1) HU228209B1 (da)
IL (1) IL139269A0 (da)
MY (1) MY128929A (da)
NO (1) NO20005483L (da)
NZ (1) NZ507902A (da)
PL (1) PL190729B1 (da)
PT (1) PT1073462E (da)
TR (1) TR200003235T2 (da)
TW (1) TW553744B (da)
WO (1) WO1999056772A2 (da)
ZA (1) ZA200006118B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1513555A (zh) * 2003-07-31 2004-07-21 长春生物制品研究所 甲-乙型肝炎联合疫苗及其冻干制剂
EP1862176A1 (de) * 2006-05-31 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) * 2006-06-01 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
CN102198270B (zh) * 2011-05-16 2012-06-27 大连汉信生物制药有限公司 一种含铝佐剂乙肝疫苗的制备方法
KR101281098B1 (ko) * 2011-06-30 2013-07-02 주식회사 녹십자 Ｂ형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도
CN102988975A (zh) * 2012-11-30 2013-03-27 深圳康泰生物制品股份有限公司 甲型、乙型肝炎联合疫苗及其制备方法
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0349686A (ja) * 1989-07-11 1991-03-04 Smithkline Biologicals Sa レトロウイルスｇａｇ蛋白の真核生物細胞における発現
DK0835663T3 (da) * 1992-05-23 2010-02-01 Glaxosmithkline Biolog Sa Kombinerede vacciner omfattende Hepatitis B overfladeantigen og andre antigener
GB9503863D0 (en) * 1995-02-25 1995-04-19 Smithkline Beecham Biolog Vaccine compositions
EP0845270B1 (en) * 1996-03-23 2004-10-27 The Research Foundation For Microbial Diseases Of Osaka University Functional fragment antigen of tetanus toxin and tetanus vaccine

Also Published As

Publication number Publication date
TR200003235T2 (tr) 2001-03-21
CN1263509C (zh) 2006-07-12
NZ507902A (en) 2002-03-28
CN1308547A (zh) 2001-08-15
NO20005483L (no) 2000-12-08
HK1034202A1 (en) 2001-10-19
CY1107322T1 (el) 2012-11-21
JP2010209118A (ja) 2010-09-24
CO5050367A1 (es) 2001-06-27
AR016987A1 (es) 2001-08-01
NO20005483D0 (no) 2000-10-31
BR9910157A (pt) 2001-01-09
CA2331086A1 (en) 1999-11-11
HUP0101652A3 (en) 2004-10-28
ATE345815T1 (de) 2006-12-15
ZA200006118B (en) 2002-01-30
JP5138843B2 (ja) 2013-02-06
PT1073462E (pt) 2007-01-31
MY128929A (en) 2007-02-28
ES2277437T3 (es) 2007-07-01
PL190729B1 (pl) 2005-12-30
EP1073462A2 (en) 2001-02-07
DE69934108D1 (de) 2007-01-04
KR100612547B1 (ko) 2006-08-11
TW553744B (en) 2003-09-21
KR20010043224A (ko) 2001-05-25
IL139269A0 (en) 2001-11-25
GC0000101A (en) 2005-06-29
WO1999056772A2 (en) 1999-11-11
HUP0101652A1 (hu) 2001-09-28
CZ20004061A3 (cs) 2001-04-11
AU743759B2 (en) 2002-02-07
WO1999056772A3 (en) 2000-02-03
EP1073462B1 (en) 2006-11-22
DE69934108T2 (de) 2007-04-19
HU228209B1 (en) 2013-01-28
CA2331086C (en) 2010-06-22
CZ301232B6 (cs) 2009-12-16
GB9809507D0 (en) 1998-07-01
JP2002513771A (ja) 2002-05-14
AU4137999A (en) 1999-11-23
PL344137A1 (en) 2001-10-08

Similar Documents

Publication Publication Date Title
NO991151D0 (no) Forbindelse og anvendelse derav
ATE335509T1 (de) Hib/dtpa impfstoff und herstellungsmethoden
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO20003303L (no) Vaksine
BR9711853A (pt) Vacinas
NO20004544L (no) Forbedret pumpeanordning og forbedrede fremgangsmÕter
ATE209045T1 (de) Hepatitis b impfstoff
DE69803330D1 (de) Einsteckbare Endklemme
FI20001715A0 (fi) Rankoihin liittyvät järjestelyt ja menetelmät
PT955810E (pt) Misturas solidas a base de sulfonilureias e adjuvantes
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
NO20001958D0 (no) Synergistiske sammensetninger omfattende et oksatiazin og et benzotiofen-2-karboksamid-S,S-dioksid
DK1073462T3 (da) Kombinationsvaccine mod hepatitis A og hepatitis B
NO995811L (no) Selvgjenopprettende og selvbekreftende kryptosystemer
NO20005502D0 (no) Polymerer og deres anvendelse
NO20005599L (no) Vaksine
DK1317478T3 (da) Skelnen mellem GnRH-I og GnRH-II
DE59706259D1 (de) Palatinalsplitschraube
ATE333894T1 (de) Vakzine gegen infektiöse bursitis
NO20006456D0 (no) En mutant human hepatitt B viral stamme og anvendelser derav
DK1105498T3 (da) HIV vaccine
DK199801305A (da) Legetøjsbyggesæt
DK1341969T3 (da) En stöjabsorberende og/eller -reducerende skærm
ITMI981384A0 (it) Vaccino per hiv
SE9902592D0 (sv) Device and a method